CSIMarket
 


Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Net Cash Flow Growth by Quarter and Year

Boston Scientific's Net Cash Flow results by quarter and year




BSX Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -287.00 -222.00 -
III Quarter September - 266.00 - -
II Quarter June - 1,316.00 - -
I Quarter March 258.00 93.00 - -14.00
FY   258.00 1,388.00 -222.00 -14.00



BSX Net Cash Flow first quarter 2021 Y/Y Growth Comment
Boston Scientific Corporation achieved in the first quarter, above Company average Net Cash Flow surge of 177.42% year on year, to $ 258.00 millions.

Looking into first quarter results within Medical Equipment & Supplies industry 19 other companies have achieved higher Net Cash Flow growth. While Boston Scientific Corporation' s Net Cash Flow doubling of 177.42% ranks overall at the positon no. 548 in the first quarter.




BSX Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March 177.42 % - - -
FY   - - - -

Financial Statements
Boston Scientific's first quarter 2021 Net Cash Flow $ 258.00 millions BSX's Income Statement
Boston Scientific's first quarter 2020 Net Cash Flow $ 93.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Net Cash Flow Growth >>


BSX Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - -79.79 % - -
II Quarter June - 1315.05 % - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #20
Healthcare Sector #88
Overall #548

Net Cash Flow Y/Y Growth Statistics
High Average Low
970.59 % 76.08 % -95.43 %
(June 30. 2015)   (Dec 31 2013)
Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #20
Healthcare Sector #88
Overall #548
Net Cash Flow Y/Y Growth Statistics
High Average Low
970.59 % 76.08 % -95.43 %
(June 30. 2015)   (Dec 31 2013)

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Boston Scientific's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
1315.05 % 173.96 % -100 %
(Jun 30 2020)  


BSX's I. Quarter Q/Q Net Cash Flow Comment
I. Quarter 2021Cyclical Boston Scientific Corporation in the influence net cash outflow of $ 258.00 millionsCyclical influence seem to have contributed Boston Scientific Corporation's return to profitability, as BSX clinchesNet Cash Flow of $ 258.00 millions in the I. Quarter 2021 coming of net cash outflow-287.00 millions in the forth quarter. Boston Scientific Corporation announced in the I. Quarter 2021 Net Cash Flow of $ 258.00 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Boston Scientific Corporation achieved highest sequential Net Cash Flow growth. While Boston Scientific's Net Cash Flow growth quarter on quarter, overall rank is 0.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Statistics
High Average Low
1315.05 % 173.96 % -100 %
(Jun 30 2020)  


BSX's I. Quarter Q/Q Net Cash Flow Comment
I. Quarter 2021Cyclical Boston Scientific Corporation in the influence net cash outflow of $ 258.00 millionsCyclical influence appear to have added to Boston Scientific Corporation's restoration of profitability, as BSX deliverNet Cash Flow of $ 258.00 millions in the I. Quarter 2021 emerging from net cash outflow-287.00 millions in the forth quarter. Boston Scientific Corporation announced in the I. Quarter 2021 Net Cash Flow of $ 258.00 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Boston Scientific Corporation achieved highest sequential Net Cash Flow growth. While Boston Scientific's Net Cash Flow growth quarter on quarter, overall rank is 0.


Boston Scientific's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Cash Flow 12 Months Ending $ 1,553.00 $ 1,388.00 $ 1,453.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) 11.89 % -4.47 % - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 548 # 914 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
Although Boston Scientific's Annual Net Cash Flow growth year on year were below company's average 1070.21% , Net Cash Flow announced in the Mar 31 2021 period, show improvement in Net Cash Flow trend, to cumulative trailing twelve month growth of 177.42% year on year, from % in Dec 31 2020. And, Boston Scientific had the highest Net Cash Flow growth, in Medical Equipment & Supplies industry.

Boston Scientific Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
970.59 %
76.08 %
-95.43 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
3600 %
1070.21 %
-90.74 %
(Dec. 30, 2014)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 88
S&P 500 # 548
Cumulative Net Cash Flow growth Comment
Although Boston Scientific's Annual Net Cash Flow growth year on year were below company's average 1070.21% , Net Cash Flow announced in the Mar 31 2021 period, show improvement in Net Cash Flow trend, to cumulative trailing twelve month growth of 177.42% year on year, from % in Dec 31 2020. And, Boston Scientific had the highest Net Cash Flow growth, in Medical Equipment & Supplies industry.

Boston Scientific Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
970.59 %
76.08 %
-95.43 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
3600 %
1070.21 %
-90.74 %
(Dec. 30, 2014)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 88
S&P 500 # 548




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BSX's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BSX's Competitors
Net Cash Flow Growth for Boston Scientific's Suppliers
Net Cash Flow Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Net Cash Flow doubling for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2021
Guardant Health Inc 305.49%$ 305.493 millions
Clearpoint Neuro Inc 296.78%$ 296.778 millions
Spectrum Pharmaceuticals Inc296.23%$ 296.225 millions
Rubius Therapeutics inc 274.24%$ 274.239 millions
Dermtech Inc 269.85%$ 269.847 millions
Otonomy Inc 246.43%$ 246.433 millions
Bicycle Therapeutics Plc241.96%$ 241.958 millions
Geron Corp224.99%$ 224.992 millions
Nuwellis Inc 206.51%$ 206.515 millions
Biohaven Pharmaceutical Holding Company Ltd 200.53%$ 200.527 millions
Orchard Therapeutics Plc195.12%$ 195.116 millions
Boston Scientific Corporation177.42%$ 177.419 millions
Eyegate Pharmaceuticals Inc158.17%$ 158.168 millions
Electrocore Inc 134.47%$ 134.474 millions
Jounce Therapeutics inc 124.28%$ 124.276 millions
Celldex Therapeutics Inc 121.69%$ 121.693 millions
Neurocrine Biosciences Inc 121.55%$ 121.553 millions
Orasure Technologies Inc120.58%$ 120.575 millions
Surgery Partners Inc 119.53%$ 119.529 millions
Chemed Corporation108.31%$ 108.314 millions
Invivo Therapeutics Holdings Corp 102.92%$ 102.924 millions
Davita Inc 99.90%$ 99.896 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AEGN's Profile

Stock Price

AEGN's Financials

Business Description

Fundamentals

Charts & Quotes

AEGN's News

Suppliers

AEGN's Competitors

Customers & Markets

Economic Indicators

AEGN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071